NCT06544200

Brief Summary

In patients undergoing minimally invasive thoracoscopic surgery (video-assisted thoracoscopic surgery, or VATS), a still unsolved issue is represented by intraoperative alveolar air leaks (IOAALs), which if prolonged beyond the fifth postoperative day can lead to higher risk of complications and higher medical costs. The polymeric hydrogel matrix (PHM) is a novel tool to manage intraoperative IOAALs. The primary end-point of our study was to verify whether PHM would be able to reduce postoperative air leaks; secondary end-points were the possible reduction of the permanence time of the chest drain (CD) and the hospital length (HL) in the PHM group compared with no treatment.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
104

participants targeted

Target at P50-P75 for not_applicable

Timeline
Completed

Started Jul 2023

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

July 15, 2023

Completed
12 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

July 13, 2024

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

July 13, 2024

Completed
17 days until next milestone

First Submitted

Initial submission to the registry

July 30, 2024

Completed
10 days until next milestone

First Posted

Study publicly available on registry

August 9, 2024

Completed
Last Updated

July 31, 2025

Status Verified

July 1, 2025

Enrollment Period

12 months

First QC Date

July 30, 2024

Last Update Submit

July 28, 2025

Conditions

Keywords

thoracoscopic surgerySegmentectomyAir LeakHydrogel Matrix

Outcome Measures

Primary Outcomes (1)

  • presence of postoperative air leaks

    The presence of postoperative air leaks from pleural drainage, from the end of surgery to the last day the air leaks are detected.

    days from end of surgery up to 40 days of postoperative follow-up

Secondary Outcomes (3)

  • Chest drain length of stay

    days from the first postoperative day up to 40 days of postoperative follow-up

  • In-Hospital length of stay

    days from the first postoperative day up to 40 days of postoperative follow-up

  • Incidence of postoperative complications

    days from the first postoperative day up to 40 days of postoperative follow-up

Study Arms (2)

Polymeric Hydrogel Matrix

EXPERIMENTAL

single application of Polymeric Hydrogel Matrix at the completion of lung resection, in patients with moderate intraoperative alveolar air leaks (30-60 ml/respiratory act), measured at the Ventilation Mechanical Test, which consists in 1 minute volumetric ventilation with a constant flow and a peak pressure of 22 cmH2O, 12 respiratory rates per minute and a positive end-expiratory pressure (PEEP) of 5 cmH2O.

Device: Polymeric Hydrogel Matrix

Control Group

NO INTERVENTION

no further treatment at the completion of lung resection, in patients with moderate intraoperative alveolar air leaks (30-60 ml/respiratory act), measured at the Ventilation Mechanical Test, which consists in 1 minute volumetric ventilation with a constant flow and a peak pressure of 22 cmH2O, 12 respiratory rates per minute and a positive end-expiratory pressure (PEEP) of 5 cmH2O.

Interventions

application of Polymeric Hydrogel Matrix along the suture line at the completion of lung resection

Polymeric Hydrogel Matrix

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • patients aged \> 18 years
  • undergoing anatomical pulmonary resection (segmentectomy) via VATS or RATS
  • benign and/or malignant lung disease
  • No known allergy to any of the components of the device

You may not qualify if:

  • Refusal or inability to give informed consent to the study protocol
  • Age \< 18 years
  • Pregnancy
  • Chronic Kidney Failure
  • Allergies or contraindications to any of the Polymeric Hydrogel Matrix components
  • Patients undergoing pulmonary resections different than segmentectomy (wedge, lobectomy, bilobectomy, pneumonectomy)
  • Patients undergoing open surgery
  • More than one chest tube after lung resection

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Thoracic Surgery Unit

Padua, 35128, Italy

Location

Related Publications (4)

  • Fuller C. Reduction of intraoperative air leaks with Progel in pulmonary resection: a comprehensive review. J Cardiothorac Surg. 2013 Apr 16;8:90. doi: 10.1186/1749-8090-8-90.

    PMID: 23590942BACKGROUND
  • Zaraca F, Vaccarili M, Zaccagna G, Maniscalco P, Dolci G, Feil B, Perkmann R, Bertolaccini L, Crisci R. Cost-effectiveness analysis of sealant impact in management of moderate intraoperative alveolar air leaks during video-assisted thoracoscopic surgery lobectomy: a multicentre randomised controlled trial. J Thorac Dis. 2017 Dec;9(12):5230-5238. doi: 10.21037/jtd.2017.11.109.

    PMID: 29312730BACKGROUND
  • Suzuki K, Saji H, Aokage K, Watanabe SI, Okada M, Mizusawa J, Nakajima R, Tsuboi M, Nakamura S, Nakamura K, Mitsudomi T, Asamura H; West Japan Oncology Group; Japan Clinical Oncology Group. Comparison of pulmonary segmentectomy and lobectomy: Safety results of a randomized trial. J Thorac Cardiovasc Surg. 2019 Sep;158(3):895-907. doi: 10.1016/j.jtcvs.2019.03.090. Epub 2019 Apr 9.

    PMID: 31078312BACKGROUND
  • Nicotra S, Comacchio GM, Mammana M, Sambataro V, Pagliarini G, Bonis A, Boemo D, Bovo P, Rebusso A, Schiavon M, Cannone G, Faccioli E, Dell'Amore A, Rea F. Air leaks management using polymeric hydrogel matrix after thoracoscopic lung segmentectomy: a single-center prospective randomized trial with a cost-effective analysis. Updates Surg. 2025 Jun 21. doi: 10.1007/s13304-025-02291-1. Online ahead of print.

MeSH Terms

Conditions

Lung Neoplasms

Condition Hierarchy (Ancestors)

Respiratory Tract NeoplasmsThoracic NeoplasmsNeoplasms by SiteNeoplasmsLung DiseasesRespiratory Tract Diseases

Study Officials

  • Samuele Nicotra, MDF

    Thoracic Surgery Unit, University Hospital of Padua

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
NONE
Purpose
TREATMENT
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Thoracic Surgeon

Study Record Dates

First Submitted

July 30, 2024

First Posted

August 9, 2024

Study Start

July 15, 2023

Primary Completion

July 13, 2024

Study Completion

July 13, 2024

Last Updated

July 31, 2025

Record last verified: 2025-07

Data Sharing

IPD Sharing
Will not share

Locations